Duke launches Murdock study
Posted on: Tuesday, 17 February 2009, 23:47 CST
Duke University said it is seeking 50,000 volunteers to donate blood for what researchers hope will be a landmark health study in North Carolina.
The long term study in Kannapolis, N.C., funded by a $35 million donation from Dole Food billionaire David Murdock, will use RNA, DNA and other molecular data to research diseases such as osteoarthritis, hepatitis C, obesity and heart disease, The Charlotte (N.C.) Observer reported Tuesday.
Project director Ashley Aull Dunham said the study, which will go for decades, has been described by Duke researchers as the Framingham for the molecular age.
Framingham is the Massachusetts town made famous by the contributions of more than 5,000 residents in helping medical researchers produce dozens of studies on heart disease, the report said.
Source: United Press International
Related Articles
- Stonegate Strategic Advisors' Research Study Provides Insight into What the Corporate Marketplace Seeks From Health and Productivity Management, Disease Management and Wellness Programs
- The N Launches Second Phase of 'The Millennial Values' Research Study As Part of Ongoing Dialogue With Teens
- Onconome Announces Completion of Breakthrough Research Study Highlighting New Blood Test for Prostate Cancer
- HealthSonix' Research Study Shows Clinically Significant Pain Reduction With Osteoarthritis Patients
- Research Study Outlines U.S. Economic Impact of Windows Vista
- New Potential Application for Stool DNA Testing Demonstrated in Research Study; EXACT Sciences' Technology Evaluated for Detection of Colorectal Cancer Associated With Inflammatory Bowel Disease
- Release of 'Where We Learn' on March 30: A New and In-Depth Research Study on Urban School Climate
- Release of 'Where We Learn': A New, In-Depth Research Study on Urban School Climate By NSBA Council of Urban Boards of Education
- New Research Studies Bring Early Detection of Alzheimer's Disease Closer to Reality
- Joint Research Study Reports Discovery of New Set of Potential Prognostic Biomarkers in Early Stage Breast Cancer at HUGO
 |
 |
User Comments (0)
RSS Feeds